Elsevier

Radiotherapy and Oncology

Volume 62, Issue 2, February 2002, Pages 215-225
Radiotherapy and Oncology

Distressful symptoms after radical radiotherapy for urinary bladder cancer

https://doi.org/10.1016/S0167-8140(01)00455-8Get rights and content

Abstract

Background: Radical radiotherapy for muscle-invasive urinary bladder cancer can sterilize the tumour with preserved organ function. Here we studied symptoms, symptom distress and trade-off among long-term survivors and compared figures to those of population controls and patients who had undergone cystectomy.

Materials and methods: We identified 71 patients who had had urinary bladder cancer treated with radical radiotherapy before 1995. For comparison, 325 patients treated with radical cystectomy and urostomy, continent or non-continent, during the same period and 460 individuals randomly selected from the general population were included. Information was collected by means of an anonymously answered postal questionnaire to avoid investigator-related bias.

Results: Answers were obtained from 58 (82%) radiated patients, 251 (85%) cystectomized patients and 310 (71%) population controls. Of the radiated patients, 74% reported little or no distress from symptoms from the urinary tract, 38% had had intercourse the previous month and 57% (men) reported they had ejaculated. Among the cystectomized patients, 13% had had intercourse and 0% (men) had ejaculated. Moderate or much distress from symptoms from the gastrointestinal tract was reported by 32% of the radiated patients, 24% of the cystectomized patients and 9% of the population controls. After radical radiotherapy, 46% of the patients were willing to accept some risk of decreased survival to become symptom-free.

Conclusions: About 3/4 of these long-term survivors after radical radiotherapy for bladder cancer had a functioning urinary bladder with little or no distress from the urinary tract. The prevalence of sexual dysfunction was lower than after cystectomy and the prevalence of distress from the gastrointestinal tract was comparable.

Introduction

In muscle-invasive urinary bladder cancer – a life-threatening disease – radiotherapy offers an attractive treatment choice, as it sterilizes the tumour while maintaining organ function. Many centres regard cystectomy as the primary therapy of choice. The urinary diversion may result in major physical and psychological changes that may chronically affect well-being [8], [13], [14], [15], [16], [17]. The function of the urinary bladder may be altered during irradiation [10]. Moreover, organs at risk include the bowel (primarily the rectum), anal sphincter, lymph vessels and the nerves and vessels involved in sexual function. A better knowledge of chronic distressful symptoms after radiotherapy can be used to prevent or relieve side effects, guide improvements in radiotherapeutic techniques and help patients to make informed treatment choices.

The rapid technological developments in radiotherapy imply that the generalizability of any historical series in today's situation at different centres is a matter of judgement. Here we report the frequencies of common distressful symptoms after radical radiotherapy for urinary bladder cancer and compare the results with those in cystectomized individuals with a urostomy and in population controls. The results reflect radiotherapy in Stockholm as given during 1977–1995.

Section snippets

Materials and methods

All patients treated with radical radiotherapy for locally aggressive urinary bladder cancer and still alive in September 1996 were identified (n=71). They were 65–86 years old. Treatments were given between January 1977 and December 1995, in Stockholm County. Radiotherapy was given in one of two different hospitals, Radiumhemmet at the Karolinska Hospital or Södersjukhuset (South Hospital). For comparisons, 325 cystectomized patients and 434 men and women randomly selected from the Swedish

Results

A total of 58 (82%) radiated, 251 (85%) cystectomized, and 310 (71%) controls returned the questionnaire. After excluding patients with recurrent cancer (nine radiated and 15 cystectomized subjects), orthotopic bladder substitution (12 cystectomized subjects) and individuals under the age of 65 (49 cystectomized patients and 49 controls), 48 radiated, (age was missing in one radiated patient) 175 cystectomized and 261 controls remained (Table 1).

Discussion

Among these long-term survivors of radical radiotherapy for urinary bladder cancer, 74% had a satisfactorily preserved organ function measured as little or no distress from the urinary tract. Moreover, the prevalence of factors related to sexual dysfunction, erectile dysfunction (men), no ejaculation during orgasm (men) and dissatisfaction with one's present sexuality (men and women) was clearly lower after radiotherapy than after cystectomy. The frequency of patients with moderate or much

Conclusion

For most patients in this series, radical radiotherapy for urinary bladder cancer resulted in preserved organ function without distress attributable to the urinary tract. Sexual function in men was better than after cystectomy, and the levels of bowel-induced distress were similar.

References (29)

  • G. Fellin et al.

    Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study

    Br J Urol

    (1997)
  • R.E. Hautmann

    Complications and results after cystectomy in male and female patients with locally invasive bladder cancer

    Eur Urol

    (1998)
  • A.R. Helgason et al.

    Waning sexual function – the most important disease-specific distress for patients with prostate cancer

    Br J Cancer

    (1996)
  • A.R. Helgason et al.

    ‘Potency’: the validation of information from a self-administered questionnaire using objective measurements of night-time erections and test-retest reliability

    Br J Urol

    (1998)
  • Cited by (0)

    View full text